Laniado Medical Center   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Netanya Israel (1975)

Organization Overview

First Clinical Trial
2010
NCT01238471
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Director of Bildirici Diabetes Center, Laniado Hospital, IL | Dr. Jinna Weissman | Laniado Hospital | Laniado Hospital Geriatric Department

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bronchopulmonary Dysplasia (Phase 2)

Dementia (Phase 2)

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Eczema (Phase 2)

Hyperplasia (Phase 2)

Ischemia (Phase 2)

Peripheral Arterial Disease (Phase 2)

Peripheral Vascular Diseases (Phase 2)

Premature Birth (Phase 2)

Psychomotor Agitation (Phase 2)

Retinal Diseases (Phase 2)

Retinopathy of Prematurity (Phase 2)

Vascular Diseases (Phase 2)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 12